- Why is early autism intervention important?
- Peer-reviewed research establishes that intervention before age 6 produces the most significant developmental gains. The Early Start Denver Model trial (Pediatrics 2010) showed that ESDM delivered to children aged 18–30 months produced significant gains in IQ, adaptive behaviour, and autism severity scores compared to controls, with some children no longer meeting diagnostic criteria at follow-up.
- What does the WHO say about autism early intervention?
- The World Health Organization's Autism fact sheet (updated Sept. 17, 2025) states that timely access to early evidence-based psychosocial interventions can improve autistic children's ability to communicate and interact socially. The WHO Comprehensive Mental Health Action Plan 2013–2030 (updated 2021) calls for countries to integrate early childhood developmental services into primary healthcare, with equitable access regardless of geography or income.
- Does Cochrane support early autism intervention?
- The Cochrane Database of Systematic Reviews (Reichow et al., 2018) found that Early Intensive Behavioural Intervention (EIBI) may produce positive effects on adaptive behaviour and communication for young children with autism. While the certainty of evidence is rated low, typical for behavioural intervention research, the direction of effect is consistent across multiple trials.
- How long is Ontario's autism waitlist relative to the early-support window?
- Ontario Autism Coalition reports 5+ years for families registered in August 2021 (community-reported, Ontario Autism Coalition, July 2026) for OAP Core Clinical Services. With 91,974 children registered and 20,711 (22.5%) in active funding, 71,263 (77.5%) are waiting. If the reported minimum applies to a child registered at age 2, they would be about 7 when an invitation arrives.
- Is it OK to wait a year before starting autism intervention?
- No. The earliest research evidence (Zwaigenbaum et al., Pediatrics 2015) supports screening and intervention commencing in the first 2 years of life. ESDM trials enrolled children at 18–30 months. Each year of delay during the 0–6 window reduces the magnitude of expected gains. There is no safe waiting period, only progressively diminishing returns.